# New York Blood Center, Inc. – FDA Inspection, Jan 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/a874a040-a344-4273-8d69-510b212ff26c
Source feed: FDA_Inspections

> FDA inspection 1195673 of New York Blood Center, Inc., January 19, 2023. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195673
- Company Name: New York Blood Center, Inc.
- Inspection Date: 2023-01-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1060491 - 2018-07-03
- FDA Inspection 962474 - 2016-03-11
- FDA Inspection 897015 - 2014-09-19
- FDA Inspection 805940 - 2012-10-26
- FDA Inspection 707602 - 2011-01-25

## Related Officers

- [Amy Kim](https://www.keypedia.com/people/amy-kim/eee8b97a-b9d0-4709-96dc-70dbadd3a6a4)

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/8dd9efce-e2e1-4ea0-9037-22533e2a70b0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d